CommuniTreat
Strategic Control of Feral and Invasive Species Populations
Company Overview
Snapshot
Founded in April 2021 by Nimrod Dahan, Itay Ben Mordechai, Dr. Tami Ehrmann Barr, and Dr. Hilik Marom, CommuniTreat operates with 1–10 employees. The company has secured funding across two rounds, with Menmon leading a Pre-Seed round in April 2022.
Business overview
CommuniTreat is developing an IP-backed bio-formula solution focused on the strategic control of feral and invasive species populations. The company's core technology involves a food-based contraceptive designed to reduce the reproductive rate of these species, thereby mitigating ecological and public health risks. CommuniTreat aims to restore balance in human-animal interactions by positioning fertility control as a cornerstone of integrated pest management, serving markets globally, including the United States and Europe, within the Agriculture & Food Technologies sector.
Log in to access full profile ›Company Intelligence Q&A
- When was CommuniTreat founded?
- CommuniTreat was founded in April 2021.
- Who are the founders of CommuniTreat?
- The founders of CommuniTreat are Nimrod Dahan, Itay Ben Mordechai, Dr. Tami Ehrmann Barr, and Dr. Hilik Marom.
- What is CommuniTreat's primary sector?
- CommuniTreat's primary sector is Agriculture & Food Technologies.
- What is CommuniTreat's employee count?
- CommuniTreat has 1–10 employees.
- What is CommuniTreat's product stage?
- CommuniTreat's product is in the Alpha stage, as of May 2024, indicating it is in early development and testing.